Keith Katkin - Director at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SNDX on Nasdaq
All Insider Reports
All Insider Reports

Keith Katkin - trading volume in the past year for Syndax Pharmaceuticals Inc

Holdings reported by Keith Katkin for Syndax Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 124,000 $2,605,240 $21.01 04 Feb 2026 Direct

Transactions reported by Keith Katkin for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.